{"id":"td1ap","safety":{"commonSideEffects":[{"rate":"10-50","effect":"Local injection site reactions (pain, redness, swelling)"},{"rate":"5-15","effect":"Fever"},{"rate":"5-10","effect":"Irritability or fussiness"},{"rate":"5-10","effect":"Drowsiness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This vaccine contains inactivated toxoids of Corynebacterium diphtheriae and Clostridium tetani, along with acellular components of Bordetella pertussis. It works by inducing both humoral and cellular immune responses, generating antibodies and memory cells that protect against diphtheria, tetanus, and pertussis infections.","oneSentence":"Td1aP is a combined diphtheria-tetanus-acellular pertussis vaccine that stimulates immune responses against three bacterial pathogens.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:11:26.863Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of diphtheria, tetanus, and pertussis in infants and children"}]},"trialDetails":[{"nctId":"NCT00870350","phase":"PHASE4","title":"An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster","status":"UNKNOWN","sponsor":"Swedish Institute for Infectious Disease Control","startDate":"2009-04","conditions":"Tetanus, Diphtheria, Pertussis","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["diTekiBooster"],"phase":"marketed","status":"active","brandName":"Td1aP","genericName":"Td1aP","companyName":"Swedish Institute for Infectious Disease Control","companyId":"swedish-institute-for-infectious-disease-control","modality":"Biologic","firstApprovalDate":"","aiSummary":"Td1aP is a combined diphtheria-tetanus-acellular pertussis vaccine that stimulates immune responses against three bacterial pathogens. Used for Prevention of diphtheria, tetanus, and pertussis in infants and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}